Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 40 entries
Sorted by: Best Match Show Resources per page
Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study.

BMC endocrine disorders

Pawaskar M, Bonafede M, Johnson B, Fowler R, Lenhart G, Hoogwerf B.
PMID: 23799930
BMC Endocr Disord. 2013 Jun 22;13:20. doi: 10.1186/1472-6823-13-20.

BACKGROUND: Type 2 diabetes is a common and costly illness, associated with significant morbidity and mortality. Despite this, there is relatively little information on the 'real-world' medication utilization patterns for patients with type 2 diabetes initiating exenatide BID or...

Cite
Pawaskar M, Bonafede M, Johnson B, et al. Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study. BMC Endocr Disord. 2013;13:20doi: 10.1186/1472-6823-13-20.
Pawaskar, M., Bonafede, M., Johnson, B., Fowler, R., Lenhart, G., & Hoogwerf, B. (2013). Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study. BMC endocrine disorders, 1320. https://doi.org/10.1186/1472-6823-13-20
Pawaskar, Manjiri, et al. "Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study." BMC endocrine disorders vol. 13 (2013): 20. doi: https://doi.org/10.1186/1472-6823-13-20
Pawaskar M, Bonafede M, Johnson B, Fowler R, Lenhart G, Hoogwerf B. Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study. BMC Endocr Disord. 2013 Jun 22;13:20. doi: 10.1186/1472-6823-13-20. PMID: 23799930; PMCID: PMC3750447.
Copy Download .nbib Format: NLM
Conformational study of cis-1,4-di-tert-butylcyclohexane by dynamic NMR spectroscopy and computational methods. Observation of chair and twist-boat conformations.

The Journal of organic chemistry

Gill G, Pawar DM, Noe EA.
PMID: 16355992
J Org Chem. 2005 Dec 23;70(26):10726-31. doi: 10.1021/jo051654z.

[reaction: see text] Low-temperature 13C NMR spectra of cis-1,4-di-tert-butylcyclohexane (1) showed signals for the twist-boat (1a) and chair (1b) conformations. 13C NMR signals were assigned to specific carbons based on the different populations, different symmetries (time-averaged C(2v) for 1a...

Cite
Gill G, Pawar DM, Noe EA. Conformational study of cis-1,4-di-tert-butylcyclohexane by dynamic NMR spectroscopy and computational methods. Observation of chair and twist-boat conformations. J Org Chem. 2005;70(26):10726-31doi: 10.1021/jo051654z.
Gill, G., Pawar, D. M., & Noe, E. A. (2005). Conformational study of cis-1,4-di-tert-butylcyclohexane by dynamic NMR spectroscopy and computational methods. Observation of chair and twist-boat conformations. The Journal of organic chemistry, 70(26), 10726-31. https://doi.org/10.1021/jo051654z
Gill, Gurvinder, et al. "Conformational study of cis-1,4-di-tert-butylcyclohexane by dynamic NMR spectroscopy and computational methods. Observation of chair and twist-boat conformations." The Journal of organic chemistry vol. 70,26 (2005): 10726-31. doi: https://doi.org/10.1021/jo051654z
Gill G, Pawar DM, Noe EA. Conformational study of cis-1,4-di-tert-butylcyclohexane by dynamic NMR spectroscopy and computational methods. Observation of chair and twist-boat conformations. J Org Chem. 2005 Dec 23;70(26):10726-31. doi: 10.1021/jo051654z. PMID: 16355992.
Copy Download .nbib Format: NLM
Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis.

Health and quality of life outcomes

Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M.
PMID: 20836888
Health Qual Life Outcomes. 2010 Sep 13;8:99. doi: 10.1186/1477-7525-8-99.

PURPOSE: It is vital to understand the associations between the medication event monitoring systems (MEMS) and self-reported questionnaires (SRQs) because both are often used to measure medication adherence and can produce different results. In addition, the economic implication of...

Cite
Shi L, Liu J, Fonseca V, et al. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8:99doi: 10.1186/1477-7525-8-99.
Shi, L., Liu, J., Fonseca, V., Walker, P., Kalsekar, A., & Pawaskar, M. (2010). Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health and quality of life outcomes, 899. https://doi.org/10.1186/1477-7525-8-99
Shi, Lizheng, et al. "Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis." Health and quality of life outcomes vol. 8 (2010): 99. doi: https://doi.org/10.1186/1477-7525-8-99
Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010 Sep 13;8:99. doi: 10.1186/1477-7525-8-99. PMID: 20836888; PMCID: PMC2944346.
Copy Download .nbib Format: NLM
Severity of hypoglycaemia and health-related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe.

Endocrinology, diabetes & metabolism

Pawaskar M, Witt EA, Engel SS, Rajpathak SN, Iglay K.
PMID: 30815548
Endocrinol Diabetes Metab. 2018 Jan 19;1(2):e00011. doi: 10.1002/edm2.11. eCollection 2018 Apr.

AIMS: Hypoglycaemia in patients with type 2 diabetes mellitus (T2DM) is associated with poor health outcomes, such as reduced health-related quality of life (HRQoL). This study aimed to assess the impact of hypoglycaemic events by severity on HRQoL, work...

Cite
Pawaskar M, Witt EA, Engel SS, et al. Severity of hypoglycaemia and health-related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe. Endocrinol Diabetes Metab. 2018;1(2):e00011doi: 10.1002/edm2.11.
Pawaskar, M., Witt, E. A., Engel, S. S., Rajpathak, S. N., & Iglay, K. (2018). Severity of hypoglycaemia and health-related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe. Endocrinology, diabetes & metabolism, 1(2), e00011. https://doi.org/10.1002/edm2.11
Pawaskar, Manjiri, et al. "Severity of hypoglycaemia and health-related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe." Endocrinology, diabetes & metabolism vol. 1,2 (2018): e00011. doi: https://doi.org/10.1002/edm2.11
Pawaskar M, Witt EA, Engel SS, Rajpathak SN, Iglay K. Severity of hypoglycaemia and health-related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe. Endocrinol Diabetes Metab. 2018 Jan 19;1(2):e00011. doi: 10.1002/edm2.11. eCollection 2018 Apr. PMID: 30815548; PMCID: PMC6354814.
Copy Download .nbib Format: NLM
Patient-centered Management of Hypothyroidism.

Indian journal of endocrinology and metabolism

Kalra S, Agarwal N, Aggarwal R, Agarwal S, Bajaj S, Bantwal G, Das AK, Ghosh S, Gupta P, Khandelwal D, Negalur V, Saboo B, Sahay R, Tiwaskar M, Unnikrishnan AG.
PMID: 28553608
Indian J Endocrinol Metab. 2017 May-Jun;21(3):475-477. doi: 10.4103/ijem.IJEM_93_17.

This communication from the National Indian Patient-centered Thyroid management group (InPACT) deals with a novel, yet essential, aspect of hypothyroidism management. The authors describe the role and scope of patient-centered care in this condition. They focus on the relevance...

Cite
Kalra S, Agarwal N, Aggarwal R, et al. Patient-centered Management of Hypothyroidism. Indian J Endocrinol Metab. 2017;21(3):475-477doi: 10.4103/ijem.IJEM_93_17.
Kalra, S., Agarwal, N., Aggarwal, R., Agarwal, S., Bajaj, S., Bantwal, G., Das, A. K., Ghosh, S., Gupta, P., Khandelwal, D., Negalur, V., Saboo, B., Sahay, R., Tiwaskar, M., & Unnikrishnan, A. G. (2017). Patient-centered Management of Hypothyroidism. Indian journal of endocrinology and metabolism, 21(3), 475-477. https://doi.org/10.4103/ijem.IJEM_93_17
Kalra, Sanjay, et al. "Patient-centered Management of Hypothyroidism." Indian journal of endocrinology and metabolism vol. 21,3 (2017): 475-477. doi: https://doi.org/10.4103/ijem.IJEM_93_17
Kalra S, Agarwal N, Aggarwal R, Agarwal S, Bajaj S, Bantwal G, Das AK, Ghosh S, Gupta P, Khandelwal D, Negalur V, Saboo B, Sahay R, Tiwaskar M, Unnikrishnan AG. Patient-centered Management of Hypothyroidism. Indian J Endocrinol Metab. 2017 May-Jun;21(3):475-477. doi: 10.4103/ijem.IJEM_93_17. PMID: 28553608; PMCID: PMC5434736.
Copy Download .nbib Format: NLM
Erratum to: Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophila reveals a species-general network of aging and metabolic genes.

Genome biology

Curtis C, Landis GN, Folk D, Wehr NB, Hoe N, Waskar M, Abdueva D, Skvortsov D, Ford D, Luu A, Badrinath A, Levine RL, Bradley TJ, Tavaré S, Tower J.
PMID: 27154433
Genome Biol. 2016 May 06;17(1):93. doi: 10.1186/s13059-016-0959-3.

No abstract available.

Cite
Curtis C, Landis GN, Folk D, et al. Erratum to: Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophila reveals a species-general network of aging and metabolic genes. Genome Biol. 2016;17(1):93doi: 10.1186/s13059-016-0959-3.
Curtis, C., Landis, G. N., Folk, D., Wehr, N. B., Hoe, N., Waskar, M., Abdueva, D., Skvortsov, D., Ford, D., Luu, A., Badrinath, A., Levine, R. L., Bradley, T. J., Tavaré, S., & Tower, J. (2016). Erratum to: Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophila reveals a species-general network of aging and metabolic genes. Genome biology, 17(1), 93. https://doi.org/10.1186/s13059-016-0959-3
Curtis, Christina, et al. "Erratum to: Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophila reveals a species-general network of aging and metabolic genes." Genome biology vol. 17,1 (2016): 93. doi: https://doi.org/10.1186/s13059-016-0959-3
Curtis C, Landis GN, Folk D, Wehr NB, Hoe N, Waskar M, Abdueva D, Skvortsov D, Ford D, Luu A, Badrinath A, Levine RL, Bradley TJ, Tavaré S, Tower J. Erratum to: Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophila reveals a species-general network of aging and metabolic genes. Genome Biol. 2016 May 06;17(1):93. doi: 10.1186/s13059-016-0959-3. PMID: 27154433; PMCID: PMC4858861.
Copy Download .nbib Format: NLM
BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Bajaj S, Das AK, Kalra S, Sahay R, Saboo B, Das S, Shunmugavelu M, Jacob J, Priya G, Khandelwal D, Dutta D, Chawla M, Surana V, Tiwaskar M, Joshi A, Shrestha PK, Bhattarai J, Bhowmik B, Latt TS, Aye TT, Vijayakumar G, Baruah M, Jawad F, Unnikrishnan AG, Chowdhury S, Pathan MF, Somasundaram N, Sumanathilaka M, Raza A, Bahendeka SK, Coetzee A, Ruder S, Ramaiya K, Lamptey R, Bavuma C, Shaikh K, Uloko A, Chaudhary S, Abdela AA, Akanov Z, Rodrìguez-Saldaña J, Faradji R, Tiago A, Reja A, Czupryniak L.
PMID: 31102253
Diabetes Ther. 2019 Aug;10(4):1189-1204. doi: 10.1007/s13300-019-0629-z. Epub 2019 May 17.

The past three decades have seen a quadruple rise in the number of people affected by diabetes mellitus worldwide, with the disease being the ninth major cause of mortality. Type 2 diabetes mellitus (T2DM) often remains undiagnosed for several...

Cite
Bajaj S, Das AK, Kalra S, et al. BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion. Diabetes Ther. 2019;10(4):1189-1204doi: 10.1007/s13300-019-0629-z.
Bajaj, S., Das, A. K., Kalra, S., Sahay, R., Saboo, B., Das, S., Shunmugavelu, M., Jacob, J., Priya, G., Khandelwal, D., Dutta, D., Chawla, M., Surana, V., Tiwaskar, M., Joshi, A., Shrestha, P. K., Bhattarai, J., Bhowmik, B., Latt, T. S., Aye, T. T., Vijayakumar, G., Baruah, M., Jawad, F., Unnikrishnan, A. G., Chowdhury, S., Pathan, M. F., Somasundaram, N., Sumanathilaka, M., Raza, A., Bahendeka, S. K., Coetzee, A., Ruder, S., Ramaiya, K., Lamptey, R., Bavuma, C., Shaikh, K., Uloko, A., Chaudhary, S., Abdela, A. A., Akanov, Z., Rodrìguez-Saldaña, J., Faradji, R., Tiago, A., Reja, A., & Czupryniak, L. (2019). BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion. Diabetes therapy : research, treatment and education of diabetes and related disorders, 10(4), 1189-1204. https://doi.org/10.1007/s13300-019-0629-z
Bajaj, Sarita, et al. "BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 10,4 (2019): 1189-1204. doi: https://doi.org/10.1007/s13300-019-0629-z
Bajaj S, Das AK, Kalra S, Sahay R, Saboo B, Das S, Shunmugavelu M, Jacob J, Priya G, Khandelwal D, Dutta D, Chawla M, Surana V, Tiwaskar M, Joshi A, Shrestha PK, Bhattarai J, Bhowmik B, Latt TS, Aye TT, Vijayakumar G, Baruah M, Jawad F, Unnikrishnan AG, Chowdhury S, Pathan MF, Somasundaram N, Sumanathilaka M, Raza A, Bahendeka SK, Coetzee A, Ruder S, Ramaiya K, Lamptey R, Bavuma C, Shaikh K, Uloko A, Chaudhary S, Abdela AA, Akanov Z, Rodrìguez-Saldaña J, Faradji R, Tiago A, Reja A, Czupryniak L. BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion. Diabetes Ther. 2019 Aug;10(4):1189-1204. doi: 10.1007/s13300-019-0629-z. Epub 2019 May 17. PMID: 31102253; PMCID: PMC6612329.
Copy Download .nbib Format: NLM
Quantifying Remission Probability in Type 2 Diabetes Mellitus.

Clinics and practice

Kalra S, Bantwal G, Kapoor N, Sahay R, Bhattacharya S, Anne B, Gopal RA, Kota S, Kumar A, Joshi A, Sanyal D, Tiwaskar M, Das AK.
PMID: 34842637
Clin Pract. 2021 Nov 09;11(4):850-859. doi: 10.3390/clinpract11040100.

Type 2 diabetes mellitus (T2DM) is a chronic progressive disorder and is associated with significant morbidity and mortality. The concept of T2DM remission and the reversal of diabetic parameters to normal levels has been gaining momentum over the past...

Cite
Kalra S, Bantwal G, Kapoor N, et al. Quantifying Remission Probability in Type 2 Diabetes Mellitus. Clin Pract. 2021;11(4):850-859doi: 10.3390/clinpract11040100.
Kalra, S., Bantwal, G., Kapoor, N., Sahay, R., Bhattacharya, S., Anne, B., Gopal, R. A., Kota, S., Kumar, A., Joshi, A., Sanyal, D., Tiwaskar, M., & Das, A. K. (2021). Quantifying Remission Probability in Type 2 Diabetes Mellitus. Clinics and practice, 11(4), 850-859. https://doi.org/10.3390/clinpract11040100
Kalra, Sanjay, et al. "Quantifying Remission Probability in Type 2 Diabetes Mellitus." Clinics and practice vol. 11,4 (2021): 850-859. doi: https://doi.org/10.3390/clinpract11040100
Kalra S, Bantwal G, Kapoor N, Sahay R, Bhattacharya S, Anne B, Gopal RA, Kota S, Kumar A, Joshi A, Sanyal D, Tiwaskar M, Das AK. Quantifying Remission Probability in Type 2 Diabetes Mellitus. Clin Pract. 2021 Nov 09;11(4):850-859. doi: 10.3390/clinpract11040100. PMID: 34842637; PMCID: PMC8628725.
Copy Download .nbib Format: NLM
Economic burden of varicella in Europe in the absence of universal varicella vaccination.

BMC public health

Pawaskar M, Méroc E, Samant S, Flem E, Bencina G, Riera-Montes M, Heininger U.
PMID: 34930179
BMC Public Health. 2021 Dec 21;21(1):2312. doi: 10.1186/s12889-021-12343-x.

BACKGROUND: Though the disease burden of varicella in Europe has been reported previously, the economic burden is still unknown. This study estimated the economic burden of varicella in Europe in the absence of Universal Varicella Vaccination (UVV) in 2018...

Cite
Pawaskar M, Méroc E, Samant S, et al. Economic burden of varicella in Europe in the absence of universal varicella vaccination. BMC Public Health. 2021;21(1):2312doi: 10.1186/s12889-021-12343-x.
Pawaskar, M., Méroc, E., Samant, S., Flem, E., Bencina, G., Riera-Montes, M., & Heininger, U. (2021). Economic burden of varicella in Europe in the absence of universal varicella vaccination. BMC public health, 21(1), 2312. https://doi.org/10.1186/s12889-021-12343-x
Pawaskar, Manjiri, et al. "Economic burden of varicella in Europe in the absence of universal varicella vaccination." BMC public health vol. 21,1 (2021): 2312. doi: https://doi.org/10.1186/s12889-021-12343-x
Pawaskar M, Méroc E, Samant S, Flem E, Bencina G, Riera-Montes M, Heininger U. Economic burden of varicella in Europe in the absence of universal varicella vaccination. BMC Public Health. 2021 Dec 21;21(1):2312. doi: 10.1186/s12889-021-12343-x. PMID: 34930179.
Copy Download .nbib Format: NLM
Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Chawla M, Jain SM, Kesavadev J, Makkar BM, Viswanathan V, Tiwaskar M, Sosale AR, Negalur V, Modi KD, Gupta M, Kumar S, Ramakrishnan S, Deka N, Roy N.
PMID: 33314000
Diabetes Ther. 2021 Jan;12(1):133-142. doi: 10.1007/s13300-020-00979-8. Epub 2020 Dec 12.

The ongoing global pandemic of the coronavirus disease 2019 (COVID-19) has placed a severe strain on the management of chronic conditions like diabetes. Optimal glycemic control is always important, but more so in the existing environment of COVID-19. In...

Cite
Chawla M, Jain SM, Kesavadev J, et al. Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel. Diabetes Ther. 2020;12(1):133-142doi: 10.1007/s13300-020-00979-8.
Chawla, M., Jain, S. M., Kesavadev, J., Makkar, B. M., Viswanathan, V., Tiwaskar, M., Sosale, A. R., Negalur, V., Modi, K. D., Gupta, M., Kumar, S., Ramakrishnan, S., Deka, N., & Roy, N. (2021). Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel. Diabetes therapy : research, treatment and education of diabetes and related disorders, 12(1), 133-142. https://doi.org/10.1007/s13300-020-00979-8
Chawla, Manoj, et al. "Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 12,1 (2021): 133-142. doi: https://doi.org/10.1007/s13300-020-00979-8
Chawla M, Jain SM, Kesavadev J, Makkar BM, Viswanathan V, Tiwaskar M, Sosale AR, Negalur V, Modi KD, Gupta M, Kumar S, Ramakrishnan S, Deka N, Roy N. Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel. Diabetes Ther. 2021 Jan;12(1):133-142. doi: 10.1007/s13300-020-00979-8. Epub 2020 Dec 12. PMID: 33314000; PMCID: PMC7733136.
Copy Download .nbib Format: NLM
QTc prolongation Safety and Effectiveness of Teneligliptin in Indian patients with type 2 Diabetes Mellitus: A real world study (QSET 2).

Diabetes & metabolic syndrome

Saboo B, Ghosh S, Tiwaskar M, Chawla R.
PMID: 34488059
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102264. doi: 10.1016/j.dsx.2021.102264. Epub 2021 Sep 01.

AIMS: To evaluate the safety with respect to QTc prolongation and effectiveness of Teneligliptin in Indian Type 2 Diabetes Mellitus (T2DM) patients.METHODS: Retrospective data of T2DM patients on teneligliptin 20 mg or 40 mg once daily as a monotherapy...

Cite
Saboo B, Ghosh S, Tiwaskar M, et al. QTc prolongation Safety and Effectiveness of Teneligliptin in Indian patients with type 2 Diabetes Mellitus: A real world study (QSET 2). Diabetes Metab Syndr. 2021;15(5):102264doi: 10.1016/j.dsx.2021.102264.
Saboo, B., Ghosh, S., Tiwaskar, M., & Chawla, R. (2021). QTc prolongation Safety and Effectiveness of Teneligliptin in Indian patients with type 2 Diabetes Mellitus: A real world study (QSET 2). Diabetes & metabolic syndrome, 15(5), 102264. https://doi.org/10.1016/j.dsx.2021.102264
Saboo, Banshi, et al. "QTc prolongation Safety and Effectiveness of Teneligliptin in Indian patients with type 2 Diabetes Mellitus: A real world study (QSET 2)." Diabetes & metabolic syndrome vol. 15,5 (2021): 102264. doi: https://doi.org/10.1016/j.dsx.2021.102264
Saboo B, Ghosh S, Tiwaskar M, Chawla R. QTc prolongation Safety and Effectiveness of Teneligliptin in Indian patients with type 2 Diabetes Mellitus: A real world study (QSET 2). Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102264. doi: 10.1016/j.dsx.2021.102264. Epub 2021 Sep 01. PMID: 34488059.
Copy Download .nbib Format: NLM
Medication Counseling for Thyroxine.

Indian journal of endocrinology and metabolism

Kalra S, Unnikrishnan AG, Tiwaskar M, Sahay R, Saboo B, Negalur V, Khandelwal D, Gupta P, Ghosh S, Das AK, Bantwal G, Bajaj S, Agarwal S, Aggarwal R, Agarwal N.
PMID: 28670549
Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):630-631. doi: 10.4103/ijem.IJEM_91_17.

This communication from the National Indian Patient-centered Thyroid Management group provides a useful tool to help in medication counseling during hypothyroidism management. The authors classify and list aspects of thyroxine use which must be discussed with patients on thyroxine...

Cite
Kalra S, Unnikrishnan AG, Tiwaskar M, et al. Medication Counseling for Thyroxine. Indian J Endocrinol Metab. 2017;21(4):630-631doi: 10.4103/ijem.IJEM_91_17.
Kalra, S., Unnikrishnan, A. G., Tiwaskar, M., Sahay, R., Saboo, B., Negalur, V., Khandelwal, D., Gupta, P., Ghosh, S., Das, A. K., Bantwal, G., Bajaj, S., Agarwal, S., Aggarwal, R., & Agarwal, N. (2017). Medication Counseling for Thyroxine. Indian journal of endocrinology and metabolism, 21(4), 630-631. https://doi.org/10.4103/ijem.IJEM_91_17
Kalra, Sanjay, et al. "Medication Counseling for Thyroxine." Indian journal of endocrinology and metabolism vol. 21,4 (2017): 630-631. doi: https://doi.org/10.4103/ijem.IJEM_91_17
Kalra S, Unnikrishnan AG, Tiwaskar M, Sahay R, Saboo B, Negalur V, Khandelwal D, Gupta P, Ghosh S, Das AK, Bantwal G, Bajaj S, Agarwal S, Aggarwal R, Agarwal N. Medication Counseling for Thyroxine. Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):630-631. doi: 10.4103/ijem.IJEM_91_17. PMID: 28670549; PMCID: PMC5477453.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 40 entries